87.49
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$87.18
Aprire:
$87.33
Volume 24 ore:
7.89M
Relative Volume:
0.66
Capitalizzazione di mercato:
$218.53B
Reddito:
$63.43B
Utile/perdita netta:
$16.42B
Rapporto P/E:
13.49
EPS:
6.4861
Flusso di cassa netto:
$14.72B
1 W Prestazione:
+3.18%
1M Prestazione:
+9.82%
6M Prestazione:
+9.58%
1 anno Prestazione:
-17.37%
Merck Co Inc Stock (MRK) Company Profile
Nome
Merck Co Inc
Settore
Industria
Telefono
908-740-4000
Indirizzo
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Confronta MRK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
MRK
Merck Co Inc
|
87.49 | 217.76B | 63.43B | 16.42B | 14.72B | 6.4861 |
|
LLY
Lilly Eli Co
|
825.45 | 736.03B | 53.26B | 13.80B | -50.20M | 15.08 |
|
JNJ
Johnson Johnson
|
190.40 | 463.72B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
227.99 | 403.22B | 58.33B | 3.73B | 18.24B | 2.1013 |
|
NVS
Novartis Ag Adr
|
130.36 | 254.84B | 53.40B | 13.68B | 16.89B | 6.8864 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-13 | Ripresa | Citigroup | Neutral |
| 2025-09-17 | Downgrade | Berenberg | Buy → Hold |
| 2025-05-14 | Downgrade | Citigroup | Buy → Neutral |
| 2025-04-22 | Iniziato | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-08 | Downgrade | Truist | Buy → Hold |
| 2024-12-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Ripresa | BofA Securities | Buy |
| 2024-12-04 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-11 | Downgrade | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Iniziato | Bernstein | Mkt Perform |
| 2024-03-11 | Downgrade | Societe Generale | Hold → Sell |
| 2024-01-04 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Buy |
| 2023-10-27 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Aggiornamento | UBS | Neutral → Buy |
| 2023-07-14 | Iniziato | HSBC Securities | Hold |
| 2023-04-13 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-03-28 | Downgrade | Societe Generale | Buy → Hold |
| 2023-03-13 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Iniziato | Jefferies | Buy |
| 2023-02-22 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Outperform |
| 2022-10-10 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-09-14 | Aggiornamento | Berenberg | Hold → Buy |
| 2022-07-06 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Ripresa | SVB Leerink | Outperform |
| 2022-04-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Iniziato | Goldman | Buy |
| 2021-12-16 | Iniziato | Daiwa Securities | Neutral |
| 2021-12-13 | Downgrade | UBS | Buy → Neutral |
| 2021-12-09 | Iniziato | Wells Fargo | Overweight |
| 2021-12-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-11-29 | Downgrade | Citigroup | Buy → Neutral |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-11-01 | Aggiornamento | Argus | Hold → Buy |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Ripresa | Truist | Buy |
| 2021-05-20 | Downgrade | Argus | Buy → Hold |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Ripresa | Bernstein | Outperform |
| 2020-09-29 | Iniziato | Berenberg | Hold |
| 2020-08-03 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-06-12 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Iniziato | Barclays | Overweight |
| 2020-01-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-16 | Iniziato | SVB Leerink | Outperform |
| 2019-07-03 | Iniziato | Mizuho | Buy |
| 2019-05-28 | Iniziato | Goldman | Neutral |
| 2019-05-13 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Reiterato | Citigroup | Buy |
| 2018-10-09 | Ripresa | Guggenheim | Buy |
| 2018-04-23 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-04-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Reiterato | Leerink Partners | Mkt Perform |
| 2018-02-07 | Reiterato | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Aggiornamento | SunTrust | Hold → Buy |
Mostra tutto
Merck Co Inc Borsa (MRK) Ultime notizie
Kornitzer Capital Management Inc. KS Grows Stock Position in Merck & Co., Inc. $MRK - MarketBeat
B & T Capital Management DBA Alpha Capital Management Acquires 4,072 Shares of Merck & Co., Inc. $MRK - MarketBeat
SSA Swiss Advisors AG Purchases 7,180 Shares of Merck & Co., Inc. $MRK - MarketBeat
Focus Partners Advisor Solutions LLC Has $6 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stake Boosted by Keeler Thomas Management LLC - MarketBeat
State of New Jersey Common Pension Fund D Sells 4,014 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Leelyn Smith LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by PKO Investment Management Joint Stock Co - MarketBeat
Cardinal Point Capital Management ULC Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Merck Q3 Earnings Preview: Issues That Will Dominate The Agenda (NYSE:MRK) - Seeking Alpha
Lee Danner & Bass Inc. Trims Stock Position in Merck & Co., Inc. $MRK - MarketBeat
West Michigan Advisors LLC Sells 35,956 Shares of Merck & Co., Inc. $MRK - MarketBeat
Sumitomo Mitsui Trust Group Inc. Has $588.68 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Sector Gamma AS Takes Position in Merck & Co., Inc. $MRK - MarketBeat
Moloney Securities Asset Management LLC Has $2.59 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Jackson Hole Capital Partners LLC Increases Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Generali Investments Towarzystwo Funduszy Inwestycyjnych - MarketBeat
ARGA Investment Management LP Raises Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
GLOBALT Investments LLC GA Trims Stake in Merck & Co., Inc. $MRK - MarketBeat
Caitong International Asset Management Co. Ltd Invests $490,000 in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by 180 Wealth Advisors LLC - MarketBeat
Bleakley Financial Group LLC Has $5.52 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Brookstone Capital Management - MarketBeat
Betamethasone Acetate Market Is Booming So Rapidly |Merck & Co., Inc., American Regent, Inc. - openPR.com
Why Some Investors Are Taking Profits on JPMorgan After Its Big Rally - The Motley Fool
Stock of the WeekMerck & Co Inc (23.10.2025) - XTB.com
FSM Wealth Advisors LLC Acquires 4,003 Shares of Merck & Co., Inc. $MRK - MarketBeat
Strata Wealth Advisors LLC Takes Position in Merck & Co., Inc. $MRK - MarketBeat
First Citizens Bank & Trust Co. Sells 17,254 Shares of Merck & Co., Inc. $MRK - MarketBeat
Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Sells 14,614 Shares of Merck & Co., Inc. $MRK - MarketBeat
Clifford Swan Investment Counsel LLC Sells 2,872 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck Keytruda formulations undergo FDA priority review for bladder cancer - Seeking Alpha
RNC Capital Management LLC Reduces Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Freedom Investment Management Inc. Grows Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Forum Financial Management LP Sells 4,413 Shares of Merck & Co., Inc. $MRK - MarketBeat
Caliber Wealth Management LLC KS Decreases Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck to Present New Data from Its Innovative Cardio-Pulmonary Pipeline and Portfolio at AHA Scientific Sessions 2025 - FinancialContent
Merck & Co., Inc. (MRK) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Cancer Drugs Market Is Booming So Rapidly | Pfizer Inc., Novartis AG, Merck & Co., Inc. - openPR.com
Ethic Inc. Buys 8,003 Shares of Merck & Co., Inc. $MRK - MarketBeat
Birch Hill Investment Advisors LLC Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat
Steel Grove Capital Advisors LLC Raises Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Family Capital Management Inc. Buys 5,122 Shares of Merck & Co., Inc. $MRK - MarketBeat
D.A. Davidson & CO. Has $43.22 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Cullen Frost Bankers Inc. Sells 8,890 Shares of Merck & Co., Inc. $MRK - MarketBeat
Avidian Wealth Enterprises LLC Decreases Holdings in Merck & Co., Inc. $MRK - MarketBeat
MRK Stock Quote Price and Forecast - CNN
Analyst Says He’s Buying Merck (MRK) as ‘Market Turns Towards Quality’ - Insider Monkey
Beech Hill Advisors Inc. Trims Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Fiduciary Family Office LLC Has $1.03 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Whittier Trust Co. of Nevada Inc. Has $21.38 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck Co Inc Azioni (MRK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):